Impact of PET-CT on primary staging and response control on multimodal treatment of esophageal cancer

World Journal of Surgery

Volumn 35, Issue 3, 2011, Pages 608-616

  Thurau, Kirsten ^a   Palmes, Daniel ^a   Franzius, Christiane ^a   Minin, Evgeny ^b   Senninger, Norbert ^a   Juergens, Kai Uwe ^a   Bruewer, Matthias ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^b UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; ADULT; AGED; ARTICLE; CANCER STAGING; COHORT ANALYSIS; COMPARATIVE STUDY; DISEASE FREE SURVIVAL; ESOPHAGUS RESECTION; ESOPHAGUS TUMOR; FEMALE; FOLLOW UP; HUMAN; KAPLAN MEIER METHOD; MALE; METHODOLOGY; MIDDLE AGED; MORTALITY; MULTIMODALITY CANCER THERAPY; NONPARAMETRIC TEST; PALLIATIVE THERAPY; PATHOLOGY; POSITRON EMISSION TOMOGRAPHY; RETROSPECTIVE STUDY; RISK ASSESSMENT; SCINTISCANNING; SENSITIVITY AND SPECIFICITY; SURVIVAL; TREATMENT OUTCOME; TUMOR RECURRENCE;

ADULT; AGED; AGED, 80 AND OVER; CHEMOTHERAPY, ADJUVANT; COHORT STUDIES; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; FEMALE; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PALLIATIVE CARE; POSITRON-EMISSION TOMOGRAPHY; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; STATISTICS, NONPARAMETRIC; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 79952183401     PISSN: 03642313     EISSN: 14322323     Source Type: Journal    
DOI: 10.1007/s00268-010-0946-x     Document Type: Article

References (31)

1. M Stahl M Stuschke N Lehmann, et al. 2005 Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus J Clin Oncol 10 2310 2317 10.1200/JCO.2005.00.034 (Pubitemid 46218723)
2. L Bedenne P Michel O Bouché, et al. 2007 Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102 J Clin Oncol 25 1160 1168 1:CAS:528:DC%2BD2sXkvFymsrs%3D 10.1200/JCO.2005.04.7118 17401004 (Pubitemid 46640561)
3. PM Schneider R Metzger H Schaefer, et al. 2008 Response evaluation by endoscopy, rebiopsy, and endoscopic ultrasound does not accurately predict histopathologic regression after neoadjuvant chemoradiation for EC Ann Surg 248 902 908 10.1097/SLA.0b013e31818f3afb 19092334
4. GW Sloof 2006 Response monitoring of neoadjuvant therapy using CT, EUS, and FDGPET Best Pract Res Clin Gastroenterol 5 941 957 10.1016/j.bpg.2006.04.004 (Pubitemid 44391342)
5. RN Williams SS Ubhi CD Sutton, et al. 2009 The early use of PET-CT alters the management of patients with esophageal cancer J Gastrointest Surg 13 868 873 1:STN:280:DC%2BD1M3ntFGlsw%3D%3D 10.1007/s11605-009-0812-z 19184245
6. F Noble D Bailey SWCIS Upper Gastrointestinal Tumour Panel, et al. 2009 Impact of integrated PET/CT in the staging of oesophageal cancer: a UK population-based cohort study Clin Radiol 64 699 705 1:STN:280: DC%2BD1MvhsVSqtQ%3D%3D 10.1016/j.crad.2009.03.003 19520214
7. JB Roedl EF Halpern RR Colen, et al. 2009 Metabolic tumor width parameters as determined on PET/CT predict disease-free survival and treatment response in squamous cell carcinoma of the esophagus Mol Imaging Biol 11 54 60 10.1007/s11307-008-0169-9 18769974
8. D Vallböhmer AH Hölscher M Dietlein, et al. 2009 [18F]-Fluorodeoxyglucose-positron emission tomography for the assessment of histopathologic response and prognosis after completion of neoadjuvant chemoradiation in esophageal cancer Ann Surg 6 888 894 10.1097/SLA. 0b013e3181bc9c0d
9. D Palmes M Weilinghoff M Colombo-Benkmann, et al. 2007 Effect of pyloric drainage procedures on gastric passage and bile reflux after esophagectomy with gastric conduit reconstruction Langenbecks Arch Surg 392 135 144 10.1007/s00423-006-0119-4 17216285 (Pubitemid 46328676)
10. ME Juweid BD Cheson 2006 Positron-emission tomography and assessment of cancer therapy N Engl J Med 5 496 50711 10.1056/NEJMra050276 (Pubitemid 43200300)
11. RJ Cerfolio AS Bryant B Ohja, et al. 2005 The accuracy of endoscopic ultrasonography with fine-needle aspiration, integrated positron emission tomography with computed tomography, and computed tomography in restaging patients with EC after neoadjuvant chemoradiotherapy J Thorac Cardiovasc Surg 129 1232 1241 10.1016/j.jtcvs.2004.12.042 15942562 (Pubitemid 40804839)
12. VJ Lowe BJ Kemp CR Jack Jr, et al. 2005 Comparison of positron emission tomography, computed tomography, and endoscopic ultrasound in the initial staging of patients with EC Mol Imaging Biol 7 422 430 10.1007/s11307-005-0017-0 16270235 (Pubitemid 44193407)
13. M Polkowski 2009 Endosonographic staging of upper intestinal malignancy Best Pract Res Clin Gastroenterol 23 649 661 1:STN:280:DC%2BD1MnhsFertg%3D%3D 10.1016/j.bpg.2009.05.002 19744630
14. EP Van Vliet MH Heijenbrok-Kal MG Hunink, et al. 2008 Staging investigations for EC: a meta-analysis Br J Cancer 98 547 557 10.1038/sj.bjc.6604200 18212745 (Pubitemid 351214529)
15. SJ Rosenbaum H Stergar G Antoch, et al. 2006 Staging and follow-up of gastrointestinal tumors with PET-CT Abdom Imaging 31 25 35 1:STN:280: DC%2BD28%2FhsFGjug%3D%3D 10.1007/s00261-005-0031-3 16333707
16. RJ Cerfolio AS Bryant 2006 Maximum standardized uptake values on positron emission tomography of esophageal cancer predicts stage, tumor biology, and survival Ann Thorac Surg 2 391 394 10.1016/j.athoracsur.2006.03.045 (Pubitemid 44080040)
17. NP Rizk L Tang PS Adusumilli, et al. 2009 Predictive value of initial PET-SUVmax in patients with locally advanced esophageal and gastroesophageal junction adenocarcinoma J Thorac Oncol 7 875 879 10.1097/JTO.0b013e3181a8cebf
18. A Salavati S Basu P Heidari, et al. 2009 Impact of fluorodeoxyglucose PET on the management of EC Nucl Med Commun 30 95 116 10.1097/MNM.0b013e32831af204 19194210
19. G Antoch N Saoudi H Kuehl, et al. 2004 Accuracy of whole-body dual-modality fluorine-18-2-fluoro-2-deoxy-D-glucose positron emission tomography and computed tomography (FDG-PET-CT) for tumor staging in solid tumors: comparison with CT and PET J Clin Oncol 21 4357 4368 10.1200/JCO.2004.08.120 (Pubitemid 41185156)
20. SG Swisher M Maish JJ Erasmus, et al. 2004 Utility of PET, CT, and EUS to identify pathologic responders in EC Ann Thorac Surg 4 1152 1160 10.1016/j.athoracsur.2004.04.046 (Pubitemid 39303827)
21. SY Song JH Kim JS Ryu, et al. 2005 FDG/PET in the prediction of pathologic response after neoadjuvant chemoradiotherapy in locally advanced, resectable EC Int J Radiat Oncol Biol Phys 4 1053 1059 (Pubitemid 41505283)
22. B Klaeser E Nitzsche JC Schuller, et al. 2009 Limited predictive value of FDG-PET for response assessment in the preoperative treatment of esophageal cancer: results of a prospective multi-center Onkologie 12 724 730 10.1159/000251842
23. JI Geh SJ Bond SM Bentzen, et al. 2006 Systematic overview of preoperative (neoadjuvant) chemoradiotherapy trials in oesophageal cancer: evidence of a radiation and chemotherapy dose response Radiother Oncol 3 236 244 10.1016/j.radonc.2006.01.009
24. G De Manzoni C Pedrazzani E Laterza, et al. 2005 Induction chemoradiotherapy for squamous cell carcinoma of the thoracic esophagus: impact of increased dosage on long-term results Ann Thorac Surg 4 1176 1183 10.1016/j.athoracsur.2005.02.048 (Pubitemid 41354085)
25. P Flamen E Van Cutsem A Lerut, et al. 2002 Positron emission tomography for assessment of the response to induction radiochemotherapy in locally advanced EC Ann Oncol 3 361 368 10.1093/annonc/mdf081 (Pubitemid 34704995)
26. JR Kroep CJ Van Groeningen MA Cuesta, et al. 2003 Positron emission tomography using 2-deoxy-2-[18F]-fluoro-D-glucose for response monitoring in locally advanced gastroesophageal cancer: a comparison of different analytical methods Mol Imaging Biol 5 337 346 10.1016/j.mibio.2003.09.007 14630513 (Pubitemid 38100894)
27. HA Wieder BL Brücher F Zimmermann, et al. 2004 Time course of tumor metabolic activity during chemoradiotherapy of esophageal squamous cell carcinoma and response to treatment J Clin Oncol 5 900 908 10.1200/JCO.2004.07. 122 (Pubitemid 41103602)
28. EA Levine MR Farmer P Clark, et al. 2006 Predictive value of 18-fluoro-deoxy-glucose positron emission tomography (18F-FDG-PET) in the identification of responders to chemoradiation therapy for the treatment of locally advanced EC Ann Surg 4 472 478 10.1097/01.sla.0000208430.07050.61
29. K Ott W Weber JR Siewert 2006 The importance of PET in the diagnosis and response evaluation of EC Dis Esophagus 6 433 442 10.1111/j.1442-2050.2006. 00617.x (Pubitemid 44644678)
30. F Lordick K Ott BJ Krause, et al. 2007 PET to assess early metabolic response and to guide treatment of adenocarcinoma of the oesophagogastric junction: the MUNICON phase II trial Lancet Oncol 9 797 805 10.1016/S1470- 2045(07)70244-9 (Pubitemid 47308659)
31. M Mamede P Abreu-E-Lima MR Oliva, et al. 2007 FDG-PET-CT tumor segmentation derived indices of metabolic activity to assess response to neoadjuvant therapy and progression-free survival in EC: correlation with histopathology results Am J Clin Oncol 4 377 388 10.1097/COC.0b013e31803993f8 (Pubitemid 47356682)